Systematic review and meta-analysis of RCTs confirms semaglutide effectively reduces body weight in overweight/obese adults both with and without type 2 diabetes, with a manageable safety profile.
Effective with or without diabetesMeta-analysis confirms semaglutide's weight loss efficacy across RCTs regardless of T2DM status
What the researchers found
Meta-analysis of RCTs confirmed semaglutide significantly reduces body weight in overweight/obese adults with or without T2DM compared to placebo, with consistent effects across multiple anthropometric and metabolic outcomes.
Why it matters
Establishes the comprehensive evidence base for semaglutide in weight management regardless of diabetes status, supporting its regulatory approval and clinical use for obesity as a standalone condition.
The numbers in context
PROSPERO-registered systematic review. Multiple RCTs included from comprehensive database search.
How the study worked
PROSPERO-registered systematic review and meta-analysis. Searched Embase, PubMed, and Cochrane Library for RCTs of semaglutide in overweight/obese adults. Evaluated body weight change, BMI, waist circumference, and safety outcomes.
Who was studied
Overweight/obese adults with and without T2DM
What this study cannot tell us
Specific numerical results weren't available in the abstract portion reviewed. Individual trial heterogeneity in doses, durations, and populations may affect pooled estimates. Publication bias is possible.
How to read the evidence
Strong evidence from a registered systematic review and meta-analysis of randomized controlled trials — the highest tier of clinical evidence.
When this study was published
Published in 2024; provides a current synthesis of semaglutide weight loss trial data.
The bigger picture
Semaglutide has transformed obesity treatment from a niche area to a mainstream medical approach. This meta-analysis consolidates the evidence that was available from individual trials, providing the strongest possible synthesis for clinical guidelines and payer decisions.
Questions still open
- What is the optimal semaglutide dose for weight loss in patients without diabetes?
- How does weight loss magnitude differ between diabetic and non-diabetic subgroups?
- What is the rate of weight regain after semaglutide discontinuation across these trials?
Common questions
Does semaglutide work for weight loss even if I don't have diabetes?
How much weight can I expect to lose on semaglutide?
Read the original research
Effectiveness and safety of semaglutide in overweight/obese adults with or without type 2 diabetes: A systematic review and meta-analysis.
Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 29, 60
Citation
Yang, Liu; Duan, Xueyu; Hua, Peng; Wu, Shilin; Liu, Xiaobo. (2024). Effectiveness and safety of semaglutide in overweight/obese adults with or without type 2 diabetes: A systematic review and meta-analysis.. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 29, 60. https://doi.org/10.4103/jrms.jrms_693_23